Comparison of Clinical Effect Between Endoscopic and Microscopic Ear Surgery of Cholesteatoma: A Multicenter Retrospective Observational Study
1 other identifier
observational
186
0 countries
N/A
Brief Summary
Background: Cholesteatoma is a potentially life-threatening inflammatory lesion that causes hearing loss, ear discharge, and ear pain, and serious complications. For the past several decades, most studies of cholesteatoma have been restricted to microscopic ear surgery. However, a growing body of evidence suggests endoscopic ear surgery is a safe, minimally invasive approach for cholesteatoma management. This thesis aim to investigate and compare the clinical effect between endoscopic and microscopic ear surgery of cholesteatoma. Materials and methods: The retrospective study included 186 patients with cholesteatoma who received endoscopic or microscopic ear surgery from 11 otorhinolaryngology centers between November 2016 and March 2021. Patients were followed-up for at least 1 year. Audiometry improvement, treatment cost, time, graft success rate and recurrence rate were assessed after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2016
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2021
CompletedFirst Submitted
Initial submission to the registry
December 21, 2021
CompletedFirst Posted
Study publicly available on registry
January 10, 2022
CompletedJanuary 10, 2022
December 1, 2021
4.4 years
December 21, 2021
January 5, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Pure Tone Average(PTA)
estimate the auditory acuity
at least 1 year
Air-Bone Gap(A-B Gap)
estimate the auditory acuity
at least 1 year
Study Arms (2)
endoscopic ear surgery group(EES)
microscopic ear surgery group(MES)
Interventions
Eligibility Criteria
1. Patients who postoperative pathologically were confirmed cholesteatoma with or without mastoid involvement. The extent of disease was confirmed by preoperative HRCT temporal bone. 2. The patients undergoed microscopic and/or endoscopic surgery for cholesteatoma including primary or revision surgery. 3. have completely clinical characteristics, follow-up data and/or postoperative audiometric data
You may qualify if:
- postoperative pathologically were confirmed cholesteatoma with or without mastoid involvement
- the extent of disease was confirmed by preoperative HRCT temporal bone
- undergoed microscopic and/or endoscopic surgery for cholesteatoma including primary or revision surgery
You may not qualify if:
- were lacking in clinical characteristics
- had not preoperative audiometric data
- missed the follow-up data
- were lacking in surgical times
- were microscopic combined endoscopic ear surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2021
First Posted
January 10, 2022
Study Start
November 1, 2016
Primary Completion
March 30, 2021
Study Completion
March 30, 2021
Last Updated
January 10, 2022
Record last verified: 2021-12